|
TRPC4AP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.777300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.018100E-02 |
| Normal-vs-Stage2 |
1.529820E-01 |
| Normal-vs-Stage3 |
2.161700E-03 |
| Normal-vs-Stage4 |
1.028030E-04 |
| Stage1-vs-Stage2 |
7.744000E-01 |
| Stage1-vs-Stage3 |
9.738200E-02 |
| Stage1-vs-Stage4 |
6.675900E-03 |
| Stage2-vs-Stage3 |
1.323770E-01 |
| Stage2-vs-Stage4 |
1.588410E-02 |
| Stage3-vs-Stage4 |
3.111200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.740900E-03 |
| Normal-vs-AfricanAmerican |
4.153200E-04 |
| Normal-vs-Asian |
3.839700E-02 |
| Caucasian-vs-AfricanAmerican |
1.138230E-01 |
| Caucasian-vs-Asian |
8.033900E-02 |
| AfricanAmerican-vs-Asian |
1.484630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.134000E-02 |
| Normal-vs-Female |
1.48860000004358E-06 |
| Male-vs-Female |
1.441810E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.815000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.166500E-04 |
| Normal-vs-Age(61-80Yrs) |
3.183700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.282200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.319000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.324000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.181000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.445400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.604600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.460800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.604260E-02 |
| Normal-vs-Grade 2 |
3.709700E-02 |
| Normal-vs-Grade 3 |
4.175900E-03 |
| Normal-vs-Grade 4 |
2.3217999999936E-05 |
| Grade 1-vs-Grade 2 |
2.126400E-01 |
| Grade 1-vs-Grade 3 |
4.955200E-01 |
| Grade 1-vs-Grade 4 |
5.966400E-01 |
| Grade 2-vs-Grade 3 |
2.500000E-01 |
| Grade 2-vs-Grade 4 |
1.557730E-03 |
| Grade 3-vs-Grade 4 |
1.182080E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.954600E-01 |
| Normal-vs-ccB subtype |
1.74639999999116E-05 |
| ccA subtype-vs-ccB subtype |
4.55150000000515E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.750100E-04 |
| Normal-vs-N1 |
1.005970E-02 |
| N0-vs-N1 |
1.712450E-02 |
|
|
